“Gemcitabine and Vinorelbine: Treatment Option in Recurrent Platinum – Resistant Ovarian Cancer”. European Journal of Oncology and Environmental Health 22, no. 3-4 (March 29, 2018): 131–137. Accessed July 18, 2024. https://mattioli1885journals.com/index.php/EJOEH/article/view/6086.